Please login to the form below

Not currently logged in
Email:
Password:

Market access webinar series begins with UK healthcare changes

Experts convene for first Sudler & Hennessey and Kantar Health online event

Kantar Health infographic

A new European stakeholder webinar series featuring market access experts from pharma, payers and beyond begins later this month with a look at the changing face of the UK healthcare scene.

Sponsored by Sudler & Hennessey and Kantar Health, the webinar series will provide a valuable survey of healthcare stakeholder trends across Europe.

The first webinar in the series will take place on Tuesday September 25 and feature a panel of Bayer Healthcare's Philip Ashman, Sue Kilby a leading UK payer, Kantar Health's Mark Sales and Sudler & Hennessey's Nick May.

Chaired by David Fisher, managing director of PMLiVE publishers the PMGroup, the webinar will cover market access trends and implications in the UK and their influence outside the country.

It will also look at how countries like the UK can learn from those who have already found ways to deal effectively with radical change.

The webinar will also see Kantar Health update its UK payer survey courtesy on how pharma can provide a win-win environment for healthcare professionals, industry and patients.

The 2011 version of the survey can be viewed via this striking interactive infographic.

Further webinars in the three-part series will examine market access developments in other European countries.

• Sign up now for the September 25 webinar at Kantar Health webinars

7th September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Complete Medical

Complete Medical delivers world-class solutions in medical communications, regulatory services, healthcare multichannel excellence, and strategic consultancy. We bring together specialist...

Latest intelligence

How to get management buy-in for content marketing
Pharma content marketing is still fairly new in the scheme of things for the pharma industry. In the conservative and traditional pharma industry that’s fraught with regulations, getting management buy-in...
EY Life Sciences Sector Update
Asia-Pacific and Japan...
A roadmap to strategic drug pricing
The current unit-based pricing model for drugs is too one-dimensional for the market's present needs. Pharma firms must identify products that will benefit from innovative pricing models, and then forge...

Infographics